Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis

Published:2020-07 Issue: Volume:151 Page:102992
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Buonerba Carlo^ORCID,Ferro Matteo,Dolce Pasquale,Crocetto Felice,Verde Antonio,Lucarelli Giuseppe^ORCID,Scafuri Luca,Facchini Sergio,Vaia Angelo,Marinelli Alfredo,Terracciano Daniela,Montella Liliana,Longo Nicola,Imbimbo Ciro,Mirone Vincenzo,Di Lorenzo Giuseppe^ORCID,De Placido Sabino,Sonpavde Guru

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference25 articles.

1. Arches: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer;Armstrong;J. Clin. Oncol.,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

3. The Sooner, the better: the establishment of a treatment paradigm in prostate cancer;Buonerba;Front. Pharmacol.,2017

4. Predictors of outcomes in patients with EGFR-Mutated non-small cell lung Cancer Receiving EGFR tyrosine kinase inhibitors: a systematic review and meta-analysis;Buonerba;Cancers,2019

5. Outcomes associated with first-line anti-PD-1/ PD-L1 agents vs. Sunitinib in patients with sarcomatoid renal cell carcinoma: a systematic review and meta-analysis;Buonerba;Cancers,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis reveals that CBX2 promotes enzalutamide resistance in prostate cancer;European Journal of Medical Research;2024-08-22

2. Predictive and Prognostic 18F-Fluorocholine PET/CT Radiomics Nomogram in Patients with Castration-Resistant Prostate Cancer with Bone Metastases Treated with 223Ra;Cancers;2024-07-29

3. High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells;Cancers;2024-07-24

4. Phyto-Photodynamic Therapy of Prostate Cancer Cells Mediated by Yemenite ‘Etrog’ Leave Extracts;Nutrients;2024-06-10

5. Predictors of Metastasis in 68GA-Prostate Specific Membrane Antigen Pet-CT in the Primary Staging of Prostate Cancer;Journal of Clinical Medicine;2024-05-08